4Q8-31521-91608
4 vaccinations
6 coded responses
25 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 840 / UT
- Registered
- 2021-02-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Dose 1 — Moderna
-
2021-02-09
Registered in v-safe
- 2021-02-12
- 2021-02-21
-
2021-02-26
Dose 2 — Moderna
- 2021-02-26
-
2021-02-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-05
-
2021-03-12
Survey response — day 14, dose 2MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-21
- 2021-03-26
- 2021-04-02
- 2021-04-11
-
2021-05-28
Survey response — 3 months, dose 2MedDRA: Hypersensitivity, Nasal congestion, Oropharyngeal pain — Feeling: GoodFree text: Allergies-sore throat, stuffy noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-27
-
2021-11-03
Dose 3 — Pfizer-BioNTech
-
2022-05-09
Survey response — 6 months, dose 3MedDRA: Cough, Ear discomfort, Headache, Oropharyngeal pain, Pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat, ear pressure, headache, body aches, coughMedDRA releases: 2024-11 · check-in free text available
-
2022-10-07
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-09
- 2022-10-23
- 2022-10-31
-
2022-11-11
Survey response — day 35, dose 4MedDRA: Headache, Nasopharyngitis, Oropharyngeal pain, Respiratory tract congestion — Feeling: FairFree text: Basic cold-headache, sore throat, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-11-19
Survey response — day 42, dose 4MedDRA: Conjunctivitis, Nasopharyngitis — Feeling: FairFree text: Basic cold symptoms. Pink eye.MedDRA releases: 2024-11 · check-in free text available
-
2023-01-06
Survey response — 3 months, dose 4MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitMedDRA releases: 2024-11
-
2023-01-06
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2023-01-10
- 2023-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Moderna | |
| 2 | 2021-02-26 | Moderna | |
| 3 | 2021-11-03 | Pfizer-BioNTech | No |
| 4 | 2022-10-07 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-01-06 | Unsuccessful |
Free text
Release 5 — day 14, dose 2
Symptoms: Headache
Release 8 — 3 months, dose 2
Symptoms: Allergies-sore throat, stuffy nose
Release 11 — 6 months, dose 3
Symptoms: Sore throat, ear pressure, headache, body aches, cough
Release 12 — day 35, dose 4
Symptoms: Basic cold-headache, sore throat, congestion
Release 12 — day 42, dose 4
Symptoms: Basic cold symptoms. Pink eye.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Conjunctivitis | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Ear discomfort | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release